Copper-2 ingestion, plus increased meat eating leading to increased copper absorption, are major factors behind the current epidemic of Alzheimer’s disease

Nutrients

Volumn 7, Issue 12, 2015, Pages 10053-10064

  Brewer, George J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Alzheimer s disease; Alzheimer s disease epidemiology; Copper plumbing; Copper supplement pills; Copper 2

Indexed keywords

CUPRIC ION; COPPER;

ALZHEIMER DISEASE; COGNITIVE DEFECT; COPPER TOXICITY; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DISEASE SEVERITY; EVIDENCE BASED PRACTICE; FOOD INTAKE; HUMAN; INTOXICATION; MEAT; MORBIDITY; PREVALENCE; REVIEW; RISK FACTOR; ANIMAL; CHEMISTRY; COGNITION; DISEASE MODEL; DRUG EFFECTS; LIVER; METABOLISM; RED MEAT;

ALZHEIMER DISEASE; ANIMALS; COGNITION; COPPER; DISEASE MODELS, ANIMAL; HUMANS; LIVER; RED MEAT; RISK FACTORS;

EID: 84949604021     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu7125513     Document Type: Review

References (44)

1. Squitti, R.; Pasqualetti, P.; dal Forno, G.; Moffa, F.; Cassetta, E.; Lupoi, D.; Vernieri, F.; Rossi, L.; Baldassini, M.; Rossini, P. M. Excess of serum copper not related to ceruloplasmin in Alzheimer disease. Neurology 2005, 64, 1040-1046. [CrossRef] [PubMed].
2. Squitti, R.; Barbati, G.; Rossi, L.; Ventriglia, M.; dal Forno, G.; Cesaretti, S.; Moffa, F.; Caridi, I.; Cassetta, E.; Pasqualetti, P.; et al. Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF β-amyloid, and h-tau. Neurology 2006, 67, 76-82. [CrossRef] [PubMed].
3. Squitti, R.; Bressi, F.; Pasqualetti, P.; Bonomini, C.; Ghidoni, R.; Binetti, G.; Cassetta, E.; Moffa, F.; Ventriglia, M.; Vernieri, F.; et al. Longitudinal prognostic value of serum "free" copper in patients with Alzheimer disease. Neurology 2009, 72, 50-55. [CrossRef] [PubMed].
4. Squitti, R.; Ghidoni, R.; Siotto, M.; Ventriglia, M.; Benussi, L.; Paterlini, A.; Magri, M.; Binetti, G.; Cassetta, E.; Caprara, D.; et al. Value of serum nonceruloplasmin copper for prediction of mild cognitive impairment conversion to Alzheimer disease. Ann. Neurol. 2014, 75, 574-580. [CrossRef] [PubMed].
5. Ceko, M. J.; Aitken, J. B.; Harris, H. H. Speciation of copper in a range of food types by X-ray absorption spectroscopy. Food Chem. 2014, 164, 50-54. [CrossRef] [PubMed].
6. Bucossi, S.; Polimanti, R.; Mariani, S.; Ventriglia, M.; Bonvicini, C.; Migliore, S.; Manfellotto, D.; Salustri, C.; Vernieri, F.; Rossini, P. M.; et al. Association of K832R and R952K SNPs of Wilson's disease gene with Alzheimer's disease. J. Alzheimers Dis. 2012, 29, 913-919. [PubMed].
7. Squitti, R.; Polimanti, R.; Bucossi, S.; Ventriglia, M.; Mariani, S.; Manfellotto, D.; Vernieri, F.; Cassetta, E.; Ursini, F.; Rossini, P. M. Linkage disequilibrium and haplotype analysis of the ATP7B gene in Alzheimer's disease. Rejuvenation Res. 2013, 16, 3-10. [CrossRef] [PubMed].
8. Squitti, R.; Polimanti, R.; Siotto, M.; Bucossi, S.; Ventriglia, M.; Mariani, S.; Vernieri, F.; Scrascia, F.; Trotta, L.; Rossini, P. M. ATP7B variants as modulators of copper dyshomeostasis in Alzheimer's disease. Neuromol. Med. 2013, 15, 515-522. [CrossRef] [PubMed].
9. Bucossi, S.; Polimanti, R.; Ventriglia, M.; Mariani, S.; Siotto, M.; Ursini, F.; Trotta, L.; Scrascia, F.; Callea, A.; Vernieri, F.; et al. Intronic rs2147363 variant in ATP7B transcription factor-binding site associated with Alzheimer's disease. J. Alzheimers Dis. 2013, 37, 453-459. [PubMed].
10. Ferri, C. P.; Prince, M.; Brayne, C.; Brodaty, H.; Fratiglioni, L.; Ganguli, M.; Hall, K.; Hasegawa, K.; Hendrie, H.; Huang, Y.; et al. Global prevalence of dementia: A Delphi consensus study. Lancet 2005, 366, 2112-2117. [CrossRef].
11. Chandra, V.; Ganguli, M.; Pandav, R.; Johnston, J.; Belle, S.; DeKosky, S. T. Prevalence of Alzheimer's disease and other dementias in rural India: The Indo-US study. Neurology 1998, 51, 1000-1008. [CrossRef] [PubMed].
12. Hendrie, H. C.; Osuntokun, B. O.; Hall, K. S.; Ogunniyi, A. O.; Hui, S. L.; Unverzagt, F. W.; Gureje, O.; Rodenberg, C. A.; Baiyewu, O.; Musick, B. S. Prevalence of Alzheimer's disease and dementia in two communities: Nigerian Africans and African Americans. Am. J. Psychiatry 1995, 152, 1485-1492. [PubMed].
13. Strachey, J.; Freud, A.; Strachey, A.; Tyson, A. 24 Volumes Entitled, The Standard Edition of the Complete Psychological Works of Sigmund Freud, Written between 1895 and 1939; The Hogarth Press: London, UK; The Institute of Psycho-Analysis: London, UK, 1966.
14. Gowers, W. R. A Manual of Diseases of the Nervous System; P. Blakiston, Son and Co: Philadelphia, PA, USA, 1888.
15. Osler, W. Modern Medicine in Theory and Practice; Lea and Febiger: Philadelphia, PA, USA; New York, NY, USA, 1910; Volume 7.
16. Boyd, W. A Textbook of Pathology: An Introduction to Medicine; Lea and Febiger: Philadelphia, PA, USA, 1938.
17. Brewer, G. J. Copper toxicity in Alzheimer's disease: Cognitive loss from ingestion of inorganic copper. J. Trace Elem. Med. Biol. 2012, 26, 89-92. [CrossRef] [PubMed].
18. Waldman, M.; Lamb, M. Dying for a Hamburger: Modern Meat Processing and the Epidemic of Alzheimer's Disease, 1st ed.; Thomas Dune Books: New York, NY, USA; St. Martin's Press: New York, NY, USA, 2005; p. 304.
19. Miyata, M.; Smith, J. D. Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and β-amyloid peptides. Nat. Genet. 1996, 14, 55-61. [CrossRef] [PubMed].
20. Moalem, S.; Percy, M. E.; Andrews, D. F.; Kruck, T. P.; Wong, S.; Dalton, A. J.; Mehta, P.; Fedor, B.; Warren, A. C. Are hereditary hemochromatosis mutations involved in Alzheimer disease? Am. J. Med. Genet. 2000, 93, 58-66. [CrossRef].
21. Zambenedetti, P.; de Bellis, G.; Biunno, I.; Musicco, M.; Zatta, P. Transferrin C2 variant does confer a risk for Alzheimer's disease in caucasians. J. Alzheimers Dis. 2003, 5, 423-427. [PubMed].
22. Seshadri, S.; Beiser, A.; Selhub, J.; Jacques, P. F.; Rosenberg, I. H.; D'Agostino, R. B.; Wilson, P. W.; Wolf, P. A. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. NEJM 2002, 346, 476-483. [CrossRef] [PubMed].
23. Grant, W. B. Dietary links to Alzheimer's disease. Alzheimers Dis. Rev. 1997, 2, 42-55.
24. Brewer, G. J. Wilson's Disease. In Harrison's Principles of Internal Medicine, 19th ed.; Kasper, D., Fauci, A., Hauser, S., Longo, D., Jameson, J. L., Loscalzo, J., Eds.; McGraw-Hill Companies: New York, NY, USA, 2015.
25. James, S. A.; Volitakis, I.; Adlard, P. A.; Duce, J. A.; Masters, C. L.; Cherny, R. A.; Bush, A. I. Elevated labile Cu is associated with oxidative pathology in Alzheimer disease. Free Radic. Biol. Med. 2012, 52, 298-302. [CrossRef] [PubMed].
26. Shen, X. L.; Yu, J. H.; Zhang, D. F.; Xie, J. X.; Jiang, H. Positive relationship between mortality from Alzheimer's disease and soil metal concentration in mainland China. J. Alzheimers Dis. 2014, 42, 893-900. [PubMed].
27. Sparks, D. L.; Schreurs, B. G. Trace amounts of copper in water induce β-amyloid plaques and learning deficits in a rabbit model of Alzheimer's disease. Proc. Natl. Acad. Sci. USA 2003, 100, 11065-11069. [PubMed].
28. Sparks, D. L.; Friedland, R.; Petanceska, S.; Schreurs, B. G.; Shi, J.; Perry, G.; Smith, M. A.; Sharma, A.; Derosa, S.; Ziolkowski, C.; et al. Trace copper levels in the drinking water, but not zinc or aluminum, influence CNS Alzheimer-like pathology. J. Nutr. Health Aging 2006, 10, 247-254. [PubMed].
29. Singh, I.; Sagare, A. P.; Coma, M.; Perlmutter, D.; Gelein, R.; Bell, R. D.; Deane, R. J.; Zhong, E.; Parisi, M.; Ciszewski, J.; et al. Low levels of copper disrupt brain amyloid-β homeostasis by altering its production and clearance. Proc. Natl. Acad. Sci. USA 2013, 110, 14771-14776. [CrossRef] [PubMed].
30. Morris, M. C.; Evans, D. A.; Tangney, C. C.; Bienias, J. L.; Schneider, J. A.; Wilson, R. S.; Scherr, P. A. Dietary copper and high saturated and trans fat intakes associated with cognitive decline. Arch. Neurol. 2006, 63, 1085-1088. [CrossRef] [PubMed].
31. Hill, G. M.; Brewer, G. J.; Juni, J. E.; Prasad, A. S.; Dick, R. D. Treatment of Wilson's disease with zinc. II. Validation of oral 64copper with copper balance. Am. J. Med. Sci. 1986, 292, 344-349. [CrossRef] [PubMed].
32. Ohrvik, H.; Thiele, D. J. How copper traverses cellular membranes through the mammalian copper transporter 1, Ctr1. Ann. N. Y. Acad. Sci. 2014, 1314, 32-41. [CrossRef] [PubMed].
33. Brewer, G. J. Copper excess, zinc deficiency, and cognition loss in Alzheimer's disease. Biofactors 2012, 38, 107-113. [CrossRef] [PubMed].
34. Ueda, K.; Kawano, H.; Hasuo, Y.; Fujishima, M. Prevalence and etiology of dementia in a Japanese community. Stroke 1992, 23, 798-803. [CrossRef] [PubMed].
35. White, L.; Petrovitch, H.; Ross, G. W.; Masaki, K. H.; Abbott, R. D.; Teng, E. L.; Rodriguez, B. L.; Blanchette, P. L.; Havlik, R. J.; Wergowske, G.; et al. Prevalence of dementia in older Japanese-American men in Hawaii: The Honolulu-Asia Aging Study. JAMA 1996, 276, 955-960. [CrossRef] [PubMed].
36. Hardy, J.; Selkoe, D. J. The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 2002, 297, 353-356. [CrossRef] [PubMed].
37. Chartier-Harlin, M. C.; Crawford, F.; Houlden, H.; Warren, A.; Hughes, D.; Fidani, L.; Goate, A.; Rossor, M.; Roques, P.; Hardy, J.; et al. Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature 1991, 353, 844-846. [CrossRef] [PubMed].
38. Sarell, C. J.; Wilkinson, S. R.; Viles, J. H. Substoichiometric levels of Cu2+ ions accelerate the kinetics of fiber formation and promote cell toxicity of amyloid-β from Alzheimer disease. J. Biol. Chem. 2010, 285, 41533-41540. [CrossRef] [PubMed].
39. Sayre, L. M.; Perry, G.; Harris, P. L.; Liu, Y.; Schubert, K. A.; Smith, M. A. In situ oxidative catalysis by neurofibrillary tangles and senile plaques in Alzheimer's disease: A central role for bound transition metals. J. Neurochem. 2000, 74, 270-279. [CrossRef] [PubMed].
40. Nunomura, A.; Tamaoki, T.; Motohashi, N.; Nakamura, M.; McKeel, D. W., Jr.; Tabaton, M.; Lee, H. G.; Smith, M. A.; Perry, G.; Zhu, X. The earliest stage of cognitive impairment in transition from normal aging to Alzheimer disease is marked by prominent RNA oxidation in vulnerable neurons. J. Neuropathol. Exp. Neurol. 2012, 71, 233-241. [CrossRef] [PubMed].
41. Lee, H. G.; Castellani, R. J.; Zhu, X.; Perry, G.; Smith, M. A. Amyloid-β in Alzheimer's disease: The horse or the cart? Pathogenic or protective? Int. J. Exp. Pathol. 2005, 86, 133-138. [CrossRef] [PubMed].
42. Brewer, G. J.; Yuzbasiyan-Gurkan, V.; Dick, R.; Wang, Y.; Johnson, V. Does a vegetarian diet controlWilson's disease? J. Am. Coll. Nutr. 1993, 12, 527-530. [CrossRef] [PubMed].
43. Sinha, R.; Cross, A. J.; Graubard, B. I.; Leitzmann, M. F.; Schatzkin, A. Meat intake and mortality: A prospective study of over half a million people. Arch. Intern. Med. 2009, 169, 562-571. [CrossRef] [PubMed].
44. Mursu, J.; Robien, K.; Harnack, L. J.; Park, K.; Jacobs, D. R., Jr. Dietary supplements and mortality rate in older women: The Iowa Women's Health Study. Arch. Intern. Med. 2011, 171, 1625-1633. [CrossRef] [PubMed].